Published:
Bio-Pharma Launch Value Maximized Through New Product Commercialization Excellence
CHAPEL HILL, N.C., July 3 /PRNewswire/ -- Bio-Pharma executives are increasingly finding value in the research products and services offered by Best Practices, LLC and in particular in use of the on-demand benchmark repository known as the Best Practice Database. (www.BestPracticeDatabase.com) Although documents from the database may be accessed and downloaded individually, many commercial and operations leaders have come to find outstanding value in membership to the database which not only provides full access to all content as needed, but also includes services such as new research alerts, invitations to participate in topical new studies and ongoing advisory services to address research needs.
One recent addition to the Best Practices Database is newly published study by Best Practices, LLC, on New Product Commercialization Excellence. The benchmarking study included such influential companies as Abbott, Allergan, Amgen, AstraZeneca, Bayer, Eli Lilly, Genentech, GSK, Merck and Novartis. Key benchmark metrics and executive insights provide a basis for informing decision-making around critical structure, resource and process planning and execution.
For a complimentary summary of the full report "Best Practices in New Product Commercialization," click on the following link http://www3.best-in-class.com/dr322.htm.
Key topic areas in the research include:
-- Early Commercialization Structure
-- Functional Involvement in Commercialization Activities
-- Cross-Functional & Regional Collaboration
-- Essential Employee Skills & Experience
-- Investment Decision Leaders
-- Value of Early Commercialization
-- Product Commercialization Success Factors
Among the key metrics gathered in this report are:
-- Commercialization Function Oversight
-- Organizational Structure
-- Commercialization Relationship with Global Marketing
-- Commercialization Leadership Levels
-- Commercialization Functional Structure
-- Commercialization Function Resources (FTEs)
-- Commercialization Functional Responsibilities
-- Commercialization Launch Responsibilities
-- Commercialization Key Stakeholders
-- Commercialization Communication
-- Product Portfolio Decision Committee Composition
-- Investment Decision Drivers
For more information on this report, contact Robert Naylor at rnaylor@best-in-class.com or (919) 767-9244. To access the full report or download a complimentary copy of the report summary, go to http://www3.best-in-class.com/dr322.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.
SOURCE Best Practices, LLC
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily News
Tags: Healthcare, north carolina
_ _Is your favorite bookmark site missing?
Ask for it.